Oral nickel tolerance: Fas ligand-expressing invariant NK T cells promote tolerance induction by eliciting apoptotic death of antigen-carrying, effete B cells

Journal of Immunology

Volumn 176, Issue 8, 2006, Pages 4581-4589

  Nowak, Michael ^a   Kopp, Frank ^a   Roelofs Haarhuis, Karin ^a   Wu, Xianzhu ^a   Gleichmann, Ernst ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; HYDROGEN PEROXIDE; NICKEL; NICKEL CHLORIDE; PROTEIN BCL 2; PROTEIN BCL XL;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; HOMEOSTASIS; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MOUSE; MOUSE STRAIN; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

EID: 33645774886     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.8.4581     Document Type: Article

References (43)

1. Lutz, M., and G. Schuler. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23: 445-449.
2. Sauter, B., M. L. Albert, L. Francisco, M. Larsson, S. Somersan, and N. Bhardwaj. 2000. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191: 423-434.
3. + T cells produce active immune unresponsiveness. J. Immunol. 168: 5589-5595.
4. Liu, K., T. Iyoda, M. Saternus, Y. Kimura, K. Inaba, and R. M. Steinman. 2002. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196: 1091-1097.
5. Kanauchi, H., F. Furukawa, and S. Imamura. 1991. Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions. J. Invest. Dermatol. 96: 478-483.
6. Hill, L. L., V. K. Shreedhar, M. L. Kripke, and L. B. Owen-Schaub. 1999. A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation. J. Exp. Med. 189: 1285-1294.
7. Schwarz, A., S. Grabbe, K. Grosse-Heitmeyer, B. Roters, H. Riemann, T. A. Luger, G. Trinchieri, and T. Schwarz. 1998. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system. J. Immunol. 160: 4262-4270.
8. Taniguchi, M., H. Koseki, T. Tokuhisa, K. Masuda, H. Sato, E. Kondo, T. Kawano, J. Cui, A. Perkes, S. Koyasu, and Y. Makino. 1996. Essential requirement of an invariant Vα14 T cell antigen receptor expression in the development of natural killer T cells. Proc. Natl. Acad. Sci. USA 93: 11025-11028.
9. Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789.
10. Hammond, K. J., and M. Kronenberg. 2003. Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr. Opin. Immunol. 15: 683-689.
11. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187: 1047-1056.
12. Seino, K. I., K. Fukao, K. Muramoto, K. Yanagisawa, Y. Takada, S. Kakuta, Y. Iwakura, L. Van Kaer, K. Takeda, T. Nakayama, et al. 2001. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc. Natl. Acad. Sci. USA 98: 2577-2581.
13. Singh, A. K., M. T. Wilson, S. Hong, D. Olivares-Villagomez, C. Du, A. K. Stanic, S. Joyce, S. Sriram, Y. Koezuka, and L. Van Kaer. 2001. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194: 1801-1811.
14. + invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J. Immunol. 173: 1043-1050.
15. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
16. D'Orazio, T. J., and J. Y. Niederkorn. 1998. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology 95: 47-55.
17. Roelofs-Haarhuis, K., X. Wu, M. Nowak, M. Fang, S. Artik, and E. Gleichmann. 2003. Infectious nickel tolerance: a reciprocal interplay of tolerogenic APCs and T suppressor cells that is driven by immunization. J. Immunol. 171: 2863-2872.
18. Sonoda, K. H., and J. Stein-Streilein. 2002. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur. J. Immunol. 32: 848-857.
19. Sonoda, K. H., D. E. Faunce, M. Taniguchi, M. Exley, S. Balk, and J. Stein-Streilein. 2001. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166: 42-50.
20. Faunce, D. E., K. H. Sonoda, and J. Stein-Streilein. 2001. MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol. 166: 313-321.
21. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626.
22. Artik, S., K. Haarhuis, X. Wu, J. Begerow, and E. Gleichmann. 2001. Tolerance to nickel: oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity. J. Immunol. 167: 6794-6803.
23. Artik, S., C. von Vultée, E. Gleichmann, T. Schwarz, and P. Griem. 1999. Nickel allergy in mice: enhanced sensitization capacity of nickel at higher oxidation states. J. Immunol. 163: 1143-1152.
24. Steinman, R. M., G. Kaplan, M. D. Witmer, and Z. A. Cohn. 1979. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J. Exp. Med. 149: 1-16.
25. + to TCR/MHC contact sites in nickel-specific human T cell activation. J. Immunol. 172: 1926-1934.
26. Weintraub, J. P., and P. L. Cohen. 1999. Ectopic expression of B7-1 (CD80) on T lymphocytes in autoimmune lpr and gld mice. Clin. Immunol. 91: 302-309.
27. Ferber, I., G. Schonrich, I. Schenkel, A. L. Mellor, G. I. Hammerling, and B. Arnold. 1994. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 263: 674-676.
28. Danadevi, K., R. Rozati, B. B. Saleha, and P. Grover. 2004. In vivo genotoxic effect of nickel chloride in mice leukocytes using comet assay. Food Chem. Toxicol. 42: 751-757.
29. L expression and blocking oxidant accumulation. Am. J. Physiol. 272: C950-C956.
30. Bates, S., and K. H. Vousden. 1999. Mechanisms of p53-mediated apoptosis. Cell. Mol. Life Sci. 55: 28-37.
31. Owen-Schaub, L. B., W. Zhang, J. C. Cusack, L. S. Angelo, S. M. Santee, T. Fujiwara, J. A. Roth, A. B. Deisseroth, W. W. Zhang, and E. Kruzel. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15: 3032-3040.
32. Miyashita, T., S. Krajewski, M. Krajewska, H. G. Wang, H. K. Lin, D. A. Liebermann, B. Hoffman, and J. C. Reed. 1994. Tumor suppressor p53 is a regulator of bcl-2 and box gene expression in vitro and in vivo. Oncogene 9: 1799-1805.
33. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
34. Weintraub, J. P., R. A. Eisenberg, and P. L. Cohen. 1997. Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice. J. Immunol. 159: 4117-4126.
35. Sy, M. S., S. D. Miller, H. B. Kowach, and H. N. Claman. 1977. A splenic requirement for the generation of suppressor T cells. J. Immunol. 119: 2095-2099.
36. + T cells to the spleen during the generation of regulatory T cells in tolerance. J. Immunol. 169: 31-38.
37. Wigginton, J. M., J. K. Lee, T. A. Wiltrout, W. G. Alvord, J. A. Hixon, J. Subleski, T. C. Back, and R. H. Wiltrout. 2002. Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-γ and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2. J. Immunol. 169: 4467-4474.
38. Lisbonne, M., P. Hachem, M. B. Tonanny, J. M. Fourneau, S. Sidobre, M. Kronenberg, P. Van Endert, M. Dy, E. Schneider, and M. C. Leite-de-Moraes. 2004. In vivo activation of invariant Vα14 natural killer T cells by α-galactosylceramide sequentially induces Fas-dependent and -independent cytotoxicity. Eur. J. Immunol. 34: 1381-1388.
39. +) T cells are required for oral and portal venous tolerance induction. J. Surg. Res. 104: 29-35.
40. Sonoda, K. H., M. Exley, S. Snapper, S. P. Balk, and J. Stein-Streilein. 1999. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190: 1215-1226.
41. Kaneko, Y., M. Harada, T. Kawano, M. Yamashita, Y. Shibata, F. Gejyo, T. Nakayama, and M. Taniguchi. 2000. Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191: 105-114.
42. Gao, Y., J. M. Herndon, H. Zhang, T. S. Griffith, and T. A. Ferguson. 1998. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. 188: 887-896.
43. Chen, Y. G., C. M. Choisy-Rossi, T. M. Holl, H. D. Chapman, G. S. Besra, S. A. Porcelli, D. J. Shaffer, D. Roopenian, S. B. Wilson, and D. V. Serreze. 2005. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J. Immunol. 174: 1196-1204.